Equasens Société anonyme

ENXTPA:EQS Lagerbericht

Marktkapitalisierung: €726.0m

Equasens Société anonyme Management

Management Kriterienprüfungen 2/4

Equasens Société anonyme CEO ist Denis Supplisson , ernannt in Apr 2022, hat eine Amtszeit von 2.58 Jahren. besitzt direkt 0% der Aktien des Unternehmens, im Wert von €508.21 . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.8 Jahre bzw. 12.9 Jahre.

Wichtige Informationen

Denis Supplisson

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer2.6yrs
Eigentum des Geschäftsführers0.00007%
Durchschnittliche Amtszeit des Managements1.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder12.9yrs

Jüngste Management Updates

Recent updates

The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 03
The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Sep 28
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price

Jul 15
Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price

Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's

Jun 22
Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's

Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Jun 07
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns

Apr 03
Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns

At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?

Mar 08
At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?

Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E

Feb 14
Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E

Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Jan 27
Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?

Nov 29
Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?

These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely

Oct 28
These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely

A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Sep 27
A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Aug 05
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15

Jun 11
Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15

Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 08
Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?

Apr 04
What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?

Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends

Feb 13
Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends

Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Jan 26
Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?

Dec 21
At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?

Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?

Dec 07
Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?

Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital

Nov 12
Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital

Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?

Oct 27
Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?

Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Oct 12
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

When Should You Buy Equasens Société anonyme (EPA:EQS)?

Sep 09
When Should You Buy Equasens Société anonyme (EPA:EQS)?

With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case

Aug 24
With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case

Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively

Jul 28
Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively

Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05

Jun 10
Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05

Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05

May 27
Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05

Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

May 22
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean

Apr 25
Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean

Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?

Feb 23
Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?

Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today

Feb 09
Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today

Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?

Jan 25
Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?

Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital

Jan 06
Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital

Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt

Nov 14
Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt

Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?

Oct 30
Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?

Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Sep 28
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?

Jul 18
Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?

Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends

Jun 24
Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends

Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?

Apr 08
Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?

Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why

Mar 24
Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why

Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 03
Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)

Feb 09
Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)

Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return

Jan 12
Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return

What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend

Dec 15
What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Denis Supplisson im Vergleich zu den Einnahmen von Equasens Société anonyme verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

€42m

Mar 31 2024n/an/a

€45m

Dec 31 2023n/an/a

€47m

Jun 30 2023n/an/a

€48m

Mar 31 2023n/an/a

€47m

Dec 31 2022€400k€176k

€46m

Jun 30 2022n/an/a

€42m

Mar 31 2022n/an/a

€41m

Dec 31 2021€353k€133k

€39m

Sep 30 2021n/an/a

€37m

Jun 30 2021n/an/a

€35m

Mar 31 2021n/an/a

€33m

Dec 31 2020€371k€133k

€31m

Sep 30 2020n/an/a

€29m

Jun 30 2020n/an/a

€27m

Mar 31 2020n/an/a

€27m

Dec 31 2019€225k€133k

€27m

Sep 30 2019n/an/a

€27m

Jun 30 2019n/an/a

€26m

Mar 31 2019n/an/a

€26m

Dec 31 2018€208k€128k

€25m

Sep 30 2018n/an/a

€25m

Jun 30 2018n/an/a

€24m

Mar 31 2018n/an/a

€24m

Dec 31 2017€189k€114k

€23m

Vergütung im Vergleich zum Markt: Unzureichende Daten, um festzustellen, ob die Gesamtvergütung von Denis im Vergleich zu Unternehmen ähnlicher Größe auf dem Markt French angemessen ist.

Entschädigung vs. Einkommen: DenisDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Denis Supplisson (55 yo)

2.6yrs

Amtszeit

€400,201

Vergütung

Mr. Denis Supplisson serves as Chief Executive Officer at Pharmagest Interactive SA since April 22, 2022. He served as Deputy Managing Director/Deputy Chief Executive Officer & Manager of the Europe Pharma...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Thierry Chapusot
Founder & Chairman of the Board14.8yrskeine Daten0.036%
€ 258.9k
Grégoire De Rotalier
Deputy CEO4.3yrs€428.66k0.000070%
€ 508.2
Denis Supplisson
Chief Executive Officer & Director2.6yrs€400.20k0.000070%
€ 508.2
Dominique Pautrat
Directorno data€330.17k0.16%
€ 1.2m
Frederique Schmidt
Group Chief Administrative & Financial Officer1.8yrskeine Datenkeine Daten
Noelle Stoulig
Head of Communicationsless than a yearkeine Datenkeine Daten
Sabrina Gharbi
Chief Human Resources Officer5.1yrskeine Datenkeine Daten
Dominique Goursaud
Head of the Medical Solutions Divisionless than a yearkeine Datenkeine Daten
Damien Valicon
Deputy MD & Head of the Pharmagest Divisionless than a yearkeine Datenkeine Daten

1.8yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrenes Management: EQSDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.8 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Thierry Chapusot
Founder & Chairman of the Board14.8yrskeine Daten0.036%
€ 258.9k
Grégoire De Rotalier
Deputy CEO4.3yrs€428.66k0.000070%
€ 508.2
Denis Supplisson
Chief Executive Officer & Director11.8yrs€400.20k0.000070%
€ 508.2
Dominique Pautrat
Director15.4yrs€330.17k0.16%
€ 1.2m
Daniel Antoine
Director22.5yrs€6.91k0.0033%
€ 24.2k
Hugues Moreaux
Director13.8yrskeine Datenkeine Daten
François Jacquel
Director13.8yrs€7.07k0.0027%
€ 20.0k
Anne Lhote
Director13.4yrskeine Daten0.0046%
€ 33.3k
Sophie Mayeux
Independent Director12.4yrs€6.76k0.00017%
€ 1.2k
Celine Gris
Independent Director7.4yrs€6.91k0.00013%
€ 943.8
Emilie Lecomte
Director7.4yrs€604.000.00011%
€ 798.6
Anne Philipona-Hintzy
Independent Director1.4yrskeine Daten0.000010%
€ 72.6

12.9yrs

Durchschnittliche Betriebszugehörigkeit

57.5yo

Durchschnittliches Alter

Erfahrener Vorstand: EQSDie Vorstandsmitglieder sind sehr erfahren ( 12.9 ).